宋杰,胡雅洁,李嘉祺,王晶晶,郭磊,郑惠文,宁若彤,王丽春,李琦涵,刘龙丁

• 1:中国医学科学院北京协和医学院医学生物学研究所云南省重大传染病疫苗研发重点实验室

摘要(Abstract)：

手足口病(hand,foot and mouth disease,HFMD)是一种全球性的传染病,其主要病原体为肠道病毒A组71型(Enterovirus group A 71,EV-A71)和柯萨奇病毒A组16型(cosackievirus A 16,CV-A16)。EV-A71感染易引发重症病例及死亡病例,而CV-A16感染所致的症状普遍较轻,且CV-A16容易引发重复感染,但目前其中的机理仍不清楚。本研究比较了EV-A71与CV-A16感染正常人呼吸道上皮细胞16HBE后I型干扰素(Type I interferon,IFN-Ι)产生相关基因的改变。结果发现EV-A71感染后TLR3、TLR7、RIG-I、MDA5、MAVS、MyD88、IRF3、IRF7、IFNα和IFNβ的基因表达量均发生了显著性地上调,而在CV-A16感染后仅MDA5显著性上调;TLR3和IRF3的基因表达水平显著性地下降,而其它基因表达水平均无显著性地变化。此外,病毒滴度和病毒拷贝数的检测结果显示,CV-A16在16HBE上的复制效率明显高于EV-A71。上述结果提示我们EV-A71和CV-A16感染16HBE对其IFN-I产生相关基因表达的影响完全不一样,且CV-A16更容易感染人呼吸道上皮细胞。本研究为EV-A71和CV-A16引起的临床症状差异的机理研究以及CV-A16重复感染的机理研究提供了线索。

关键词(KeyWords)： 手足口病;肠道病毒A组71型(EV-A71);柯萨奇病毒A组16型(CV-A16);呼吸道上皮细胞;干扰素

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目(项目号:81373142),题目:肠道病毒71型感染相关的免疫分子转录组学研究;; 云南省科技计划项目生物重大科技专项(项目号:2015GA010),题目:EV71-CoxA16联合疫苗的研究及其他疫苗研究

作者(Author): 宋杰,胡雅洁,李嘉祺,王晶晶,郭磊,郑惠文,宁若彤,王丽春,李琦涵,刘龙丁

DOI: 10.13242/j.cnki.bingduxuebao.003064

参考文献(References)：

• [1]McMinn P C.Recent advances in the molecular epidemiology and control of human enterovirus 71infection[J].Curr Opin Virol,2012,2(2):199-205.
• [2]Ng Q,He F and Kwang J.Recent progress towards novel EV71anti-therapeutics and vaccines[J].Viruses,2015,7(12):6441-6457.
• [3]Pu J,Huang H,Zhang Y,et al.The structure,pathogenicity and immunogenicity of two virion fractions harvested from cell cultures infected with the CA16virus[J].Intervirology,2015,58(4):260-269.
• [4]Song J,Hu Y,Hu Y,et al.Global gene expression analysis of peripheral blood mononuclear cells in rhesus monkey infants with CA16infection-induced HFMD[J].Virus Res,2016,214:1-10.
• [5]Li J,Sun Y,Du Y,et al.Characterization of Coxsackievirus A6-and Enterovirus 71-Associated Hand Foot and Mouth Disease in Beijing,China,from 2013to 2015[J].Front Microbiol,2016,7:391.
• [6]Li J P,Liao Y,Zhang Y,et al.Experimental infection of tree shrews(Tupaia belangeri)with Coxsackie virus A16[J].Dongwuxue Yanjiu,2014,35(6):485-491.
• [7]Wang J,Qi S,Zhang X,et al.Coxsackievirus A 16infection does not interfere with the specific immune response induced by an enterovirus 71inactivated vaccine in rhesus monkeys[J].Vaccine,2014,32(35):4436-4442.
• [8]Isaacs A,Lindenmann J and Valentine R C.Virus interference.II.Some properties of interferon[J].Proc R Soc Lond B Biol Sci,1957,147(927):268-273.
• [9]Ivashkiv L B and Donlin L T.Regulation of type I interferon responses[J].Nat Rev Immunol,2014,14(1):36-49.
• [10]Theofilopoulos A N,Gonzalez-Quintial R,Lawson B R,et al.Sensors of the innate immune system:their link to rheumatic diseases[J].Nat Rev Rheumatol,2010,6(3):146-156.
• [11]Kawai T and Akira S.TLR signaling[J].Cell Death Differ,2006,13(5):816-825.
• [12]Teijaro J R.Type I interferons in viral control and immune regulation[J].Curr Opin Virol,2016,16:31-40.
• [13]Klein Klouwenberg P,Tan L,Werkman W,et al.The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus[J].Crit Rev Immunol,2009,29(6):531-550.
• [14]Tan C W,Lai J K,Sam I C,et al.Recent developments in antiviral agents against enterovirus 71infection[J].J Biomed Sci,2014,21:14.
• [15]Hashimoto K,Graham B S,Ho S B,et al.Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5[J].Am J Respir Crit Care Med,2004,170(3):306-312.
• [16]Iwasaki A and Medzhitov R.Control of adaptive immunity by the innate immune system[J].Nat Immunol,2015,16(4):343-353.
• [17]Pfaller C K,Li Z,George C X,et al.Protein kinase PKR and RNA adenosine deaminase ADAR1:new roles for old players as modulators of the interferon response[J].Curr Opin Immunol,2011,23(5):573-582.
• [18]Lei X,Sun Z,Liu X,et al.Cleavage of the adaptor protein TRIF by enterovirus 71 3Cinhibits antiviral responses mediated by Toll-like receptor 3[J].J Virol,2011,85(17):8811-8818.
• [19]Xu C,He X,Zheng Z,et al.Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response[J].J Virol,2014,88(19):11356-11368.
• [20]Liu Y,Zhang Z,Zhao X,et al.Enterovirus 71inhibits cellular type I interferon signaling by downregulating JAK1protein expression[J].Viral Immunol,2014,27(6):267-276.